Mayo Clinic Study Links Anemia Drugs with Leukemia

A recent Mayo Clinic study has shown a potential link between an increased risk in leukemia and the anemia drugs Aranesp, Epogen, and Procrit. According to Dr. Ayalew Tefferi, Mayo Clinic hematologist, “While we cannot take these findings as an absolute, at the same time, they cannot be ignored, treatment decisions regarding the use of anemia drugs in patients with primary myelofibrosis should carefully be evaluated.”